ArticleBiomedicines2023

Survival Benefit after Shifting from Upfront Surgery to Neoadjuvant Treatment in Borderline Resectable Pancreatic Cancer.

Hyun Jeong Jeon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.